Suppr超能文献

一氧化氮合酶抑制剂减弱大鼠蓝斑中急性和慢性吗啡戒断反应:一项体内伏安法研究。

Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.

作者信息

Hall S, Milne B, Jhamandas K

机构信息

Department of Pharmacology and Toxicology, Queen's University, Kingston, Ont, Canada.

出版信息

Brain Res. 1996 Nov 11;739(1-2):182-91. doi: 10.1016/s0006-8993(96)00823-2.

Abstract

Previous studies have demonstrated that activation of N-methyl-D-aspartate (NMDA) and non-NMDA receptors contributes to the hyperactivity of noradrenergic neurons of the locus coeruleus (LC) associated with opioid and non-opioid drug withdrawal syndromes. Using an in vivo voltammetric approach, we have examined the role of nitric oxide (NO), which mediates NMDA receptor function, in this withdrawal-induced LC hyperactivity. In the anaesthetized rat, acute morphine treatment (10 micrograms, i.c.v.) suppressed (55.7 +/- 4.4% of baseline) the catechol oxidation current (CA-OC) recorded from the LC using differential normal pulse voltammetry (DNPV). A subsequent intravenous injection of naloxone (2 mg/kg, i.v.) reversed the drug-induced inhibition of LC response and produced an increase (118.9 +/- 2.3% of baseline) in CA-OC above baseline, indicative of an acute withdrawal response. Systemic (100 mg/kg) and intracerebroventricular (i.c.v.) (100 micrograms) pretreatment of animals with the nitric oxide synthase inhibitor N omega-nitro-L-arginine methyl ester (L-NAME) blocked the naloxone-induced LC withdrawal response without influencing the inhibitory effect of morphine on LC activity. In animals chronically infused with morphine (15 micrograms/h, i.c.v., 5 days) a naloxone challenge (2 mg/kg, i.v.) produced significant increase (253.7 +/- 19.3% of baseline) in CA-OC signal. This LC withdrawal response was significantly reduced by pretreatment with L-NAME (100 micrograms, i.c.v.) or N omega-nitro-L-arginine (L-NOARG 10 micrograms, i.c.v.). In unanaesthetized animals pretreated with chronic morphine, systemic (100 mg/kg) and central L-NAME (100 micrograms) pretreatment suppressed some of the behavioural signs of withdrawal precipitated by naloxone (10 mg/kg) injection. As doses of the NOS inhibitors used in this study have previously been reported to produce significant inhibition of brain NOS activity, their effect on opioid withdrawal response most likely is due to NOS inhibition. The results of this study indicate that NO plays an intermediary role in the LC neuronal hyperactivity associated with both acute and chronic morphine withdrawal.

摘要

先前的研究表明,N-甲基-D-天冬氨酸(NMDA)和非NMDA受体的激活与阿片类和非阿片类药物戒断综合征相关,会导致蓝斑(LC)去甲肾上腺素能神经元的活动亢进。我们采用体内伏安法,研究了介导NMDA受体功能的一氧化氮(NO)在这种戒断诱导的LC活动亢进中的作用。在麻醉大鼠中,急性吗啡治疗(10微克,脑室内注射)使用差分正常脉冲伏安法(DNPV)抑制了(基线的55.7±4.4%)从LC记录的儿茶酚氧化电流(CA-OC)。随后静脉注射纳洛酮(2毫克/千克,静脉注射)逆转了药物诱导的LC反应抑制,并使CA-OC比基线增加(基线的118.9±2.3%),表明有急性戒断反应。用一氧化氮合酶抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME)对动物进行全身(100毫克/千克)和脑室内(脑室内注射)(100微克)预处理,可阻断纳洛酮诱导的LC戒断反应,而不影响吗啡对LC活动的抑制作用。在长期输注吗啡(15微克/小时,脑室内注射,5天)的动物中,纳洛酮激发(2毫克/千克,静脉注射)使CA-OC信号显著增加(基线的253.7±19.3%)。用L-NAME(100微克,脑室内注射)或Nω-硝基-L-精氨酸(L-NOARG 10微克,脑室内注射)预处理可显著降低这种LC戒断反应。在经慢性吗啡预处理的未麻醉动物中,全身(100毫克/千克)和中枢L-NAME(100微克)预处理可抑制纳洛酮(10毫克/千克)注射诱发的一些戒断行为体征。由于本研究中使用的NOS抑制剂剂量先前已报道可显著抑制脑NOS活性,它们对阿片类戒断反应之作用很可能归因于NOS抑制。本研究结果表明,NO在与急性和慢性吗啡戒断相关的LC神经元活动亢进中起中介作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验